NeuroBo Pharmaceuticals Securities Offering Presentation Deck
October 2022, 30 slides
  1. NeuroBo Pharmaceuticals
  2. Related Decks
  3. Securities Offering Presentation Decks
pharmaceuticals | NeuroBo Pharmaceuticals
forward looking statements | NeuroBo Pharmaceuticals
free writing prospectus | NeuroBo Pharmaceuticals
company overview a dong a equity capital | NeuroBo Pharmaceuticals
license agreement with dong a | NeuroBo Pharmaceuticals
pipeline and near term catalysts | NeuroBo Pharmaceuticals
anticipated catalysts | NeuroBo Pharmaceuticals
a novel protein coupled receptor agonist with potential for non alcoholic nash synthetic small molecule selective and suitable for oral administration i ale | NeuroBo Pharmaceuticals
mechanism of action in nash | NeuroBo Pharmaceuticals
attenuates nash progression in obese nash mice | NeuroBo Pharmaceuticals
therapeutic potential of in diet induced obesity nash mice | NeuroBo Pharmaceuticals
clinical trials to date phase and | NeuroBo Pharmaceuticals
nash upcoming study overview phase to establish signal efficacy in nash a | NeuroBo Pharmaceuticals
a novel analogue functioning as a dual agonist for the treatment of nash and obesity once weekly administration is | NeuroBo Pharmaceuticals
mechanism of action | NeuroBo Pharmaceuticals
mechanism of action of body weight loss | NeuroBo Pharmaceuticals
therapeutic potential obesity | NeuroBo Pharmaceuticals
therapeutic potential for nash further improved hepatic steatosis inflammation and fibrosis compared to seme mouse | NeuroBo Pharmaceuticals
therapeutic potential for nash | NeuroBo Pharmaceuticals
obesity nash upcoming study overviews a | NeuroBo Pharmaceuticals
market opportunity financial overview | NeuroBo Pharmaceuticals
developing assets targeting significant opportunities of unmet need | NeuroBo Pharmaceuticals
product differentiation | NeuroBo Pharmaceuticals
and obesity management in adults with or overweight with at least one weight related conditions high blood pressure or high cholesterol | NeuroBo Pharmaceuticals
tangible universe of successful early stage metabolic | NeuroBo Pharmaceuticals
and capitalization table | NeuroBo Pharmaceuticals
the team | NeuroBo Pharmaceuticals
intellectual property rights spy | NeuroBo Pharmaceuticals
business development opportunities legacy assets | NeuroBo Pharmaceuticals
pharmaceuticals iliac | NeuroBo Pharmaceuticals
See More
NeuroBo Pharmaceuticals
Securities Offering Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Pharmaceutical
Inflammation
Recent decks by NeuroBo Pharmaceuticals
Investor Presentation
January 2024
Investor Presentation
December 2023
Investor Presentation
March 2021
See all presentations by NeuroBo Pharmaceuticals (4 decks)
Related decks
Doximity
Investor Presentation
November 2023
Doximity
IPO
May 2023
Comera
Investor Presentation
December 2023
Tonix Pharmaceuticals
Investor Presentation
October 2022
Doximity
Investor Presentation
June 2023
Doximity
Investor Presentation
May 2022
Equillium
Investor Presentation
February 2024
Doximity
Investor Presentation
August 2023
Recent decks by NeuroBo Pharmaceuticals
See all presentations (4 decks)
Investor Presentation
January 2024
Investor Presentation
December 2023
Investor Presentation
March 2021
Doximity
Investor Presentation
November 2023
Doximity
IPO
May 2023
Comera
Investor Presentation
December 2023
Tonix Pharmaceuticals
Investor Presentation
October 2022
Doximity
Investor Presentation
June 2023
Doximity
Investor Presentation
May 2022
Equillium
Investor Presentation
February 2024
Doximity
Investor Presentation
August 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io